GR3033079T3 - Tricyclic pteridinones and a process for their preparation. - Google Patents

Tricyclic pteridinones and a process for their preparation.

Info

Publication number
GR3033079T3
GR3033079T3 GR20000400768T GR20000400768T GR3033079T3 GR 3033079 T3 GR3033079 T3 GR 3033079T3 GR 20000400768 T GR20000400768 T GR 20000400768T GR 20000400768 T GR20000400768 T GR 20000400768T GR 3033079 T3 GR3033079 T3 GR 3033079T3
Authority
GR
Greece
Prior art keywords
pteridinones
tricyclic
preparation
compounds
tricyclic pteridinones
Prior art date
Application number
GR20000400768T
Other languages
English (en)
Inventor
David D Davey
John William Lampe
Original Assignee
Berlex Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlex Lab filed Critical Berlex Lab
Publication of GR3033079T3 publication Critical patent/GR3033079T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR20000400768T 1989-11-17 2000-03-28 Tricyclic pteridinones and a process for their preparation. GR3033079T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43757489A 1989-11-17 1989-11-17

Publications (1)

Publication Number Publication Date
GR3033079T3 true GR3033079T3 (en) 2000-08-31

Family

ID=23736999

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000400768T GR3033079T3 (en) 1989-11-17 2000-03-28 Tricyclic pteridinones and a process for their preparation.

Country Status (8)

Country Link
EP (1) EP0429149B1 (el)
JP (1) JP3026020B2 (el)
AT (1) ATE188475T1 (el)
CA (1) CA2029651C (el)
DE (1) DE69033414T2 (el)
DK (1) DK0429149T3 (el)
ES (1) ES2145733T3 (el)
GR (1) GR3033079T3 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602252A (en) * 1989-11-17 1997-02-11 Berlex Laboratories, Inc. Tricyclic pteridinones and a process for their preparation
US5854419A (en) * 1989-11-17 1998-12-29 Schering Aktiengesellschaft Tricyclic pteridinones and a process for their preparation
US6410726B1 (en) 2000-01-12 2002-06-25 Tularik Inc. Arylsulfonic acid salts of pyrimidine-based antiviral
CN1551881A (zh) * 2001-09-04 2004-12-01 ���ָ��Ӣ��ķ�������Ϲ�˾ 新颖二氢喋啶酮,其制备方法及作为药物组合物的用途
US6806272B2 (en) 2001-09-04 2004-10-19 Boehringer Ingelheim Pharma Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
EP1312365A1 (de) * 2001-11-20 2003-05-21 Jenapharm GmbH & Co. KG Pteridinone zur Behandlung der erektilen Dysfunktion
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
EP1632493A1 (de) 2004-08-25 2006-03-08 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
TWI315304B (en) * 2006-08-31 2009-10-01 Univ Taipei Medical Indoline-sulfonamides compounds
WO2009019205A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
MX2012007273A (es) * 2009-12-23 2012-12-17 Elan Pharm Inc Pteridinonas como inhibidores de la quinasa tipo polo.
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
CN102408380B (zh) * 2011-12-22 2014-04-16 浙江大学 5-氨基嘧啶硫酮类化合物及其制备方法
WO2015011236A1 (en) 2013-07-26 2015-01-29 Boehringer Ingelheim International Gmbh Treatment of myelodysplastic syndrome
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2940654A1 (de) * 1979-10-06 1981-04-16 Bayer Ag, 5090 Leverkusen Dimeres keten der 1,2,,-triazol-3-carbonsaeure
US4440929A (en) * 1981-07-16 1984-04-03 Usv Pharmaceutical Corporation Imidazoquinoxaline compounds
WO1988002370A1 (en) * 1986-09-30 1988-04-07 Ciba-Geigy Ag 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines pharmaceutical compositions and uses thereof

Also Published As

Publication number Publication date
EP0429149B1 (en) 2000-01-05
CA2029651A1 (en) 1991-05-18
CA2029651C (en) 2000-06-06
JP3026020B2 (ja) 2000-03-27
DE69033414D1 (de) 2000-02-10
DE69033414T2 (de) 2000-08-03
EP0429149A1 (en) 1991-05-29
DK0429149T3 (da) 2000-06-13
ES2145733T3 (es) 2000-07-16
JPH03170482A (ja) 1991-07-24
ATE188475T1 (de) 2000-01-15

Similar Documents

Publication Publication Date Title
GR3033079T3 (en) Tricyclic pteridinones and a process for their preparation.
HU885889D0 (en) Process for the production of azaspirane derivatives
GR3032611T3 (en) Imidazoquinoxalinones, their aza analogs and process for their preparation.
DE3571436D1 (en) New pharmaceutical compositions having anti-psychotic properties
CA2077695A1 (en) Hydropyridine derivatives having antithrombotic activity
HU908367D0 (en) Process for the production of compounds with improved quality
HUT42080A (en) Process for producing labdane derivatives and pharmaceutical compositions containing them
ATE63913T1 (de) Pyrazolo(3,4-b)pyridinderivate und verfahren zu ihrer herstellung.
ES8406467A1 (es) "procedimiento para preparar nuevos benzo b tiofenos".
HUT48231A (en) Process for producing 2-phenylbenzoxepin derivatives and pharmaceutical compositions comprising such compounds
HUT51298A (en) Process for producing retarde hirudine derivatives and pharmaceutical compositions containing them as active components
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
LV10235B (en) New esters, method of preparation thereof, pharmaceutical composition and method of treatment
HUT35680A (en) Process for preparing purine derivatives
HUT54362A (en) Process for producing cumarin derivatives and pharmaceutical compositions containing them
PT86282A (en) Novel anthracyclinederivates a process for preparing and pharmaceutical compounds containing them
FR2364913A1 (fr) Nouveaux derives du benzopyranne utiles comme medicaments et leur procede de preparation
DZ1407A1 (fr) Dérivés d-substitués des n,n'-ditriméthoxybenzoylepipérazine ainsi que leur procédé de préparation.
PT77850B (en) Process for preparing new pharmacologically active pyrazolopyridines and of pharmaceutical compositions containing the same
MY103368A (en) 1,3-dioxanes
HUT52698A (en) Process for producing pharmaceutical compositions for treating autoimmune leucoencephalomyelitis like diseases as sclerosis multiplex
HUT49125A (en) Process for producing new 2-thiazolidinone derivatives and pharmaceutical compositions containing them
EP0096356A3 (en) The novel microorganism strain chromobacterium violaceum, pharmaceutically active compounds being produced by the strain, a process for preparing the compounds and the use of these compounds as medicaments
IL59209A (en) Analogs of prostacyclin,processes for their preparation and pharmaceutical compositions containing them
ES2064652T3 (es) Derivados de naftaleno- y tetrahidronaftaleno-gem-difosfonato.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees